Steen H. Ingwersen
Copenhagen, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Preserved pharmacokinetics and pharmacodynamics of insulin degludec and liraglutide when administered as insulin degludec/liraglutide in a Chinese population.
Journal: Journal of diabetes investigation
Published: August 11, 2021
Levels of circulating semaglutide determine reductions in HbA1c and body weight in people with type 2 diabetes.
Journal: Cell reports. Medicine
Published: April 20, 2021
Clinical Pharmacokinetics of Oral Semaglutide: Analyses of Data from Clinical Pharmacology Trials.
Journal: Clinical pharmacokinetics
Published: April 12, 2021
Population Pharmacokinetics of Semaglutide for Type 2 Diabetes.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: February 04, 2019
Semaglutide s.c. Once-Weekly in Type 2 Diabetes: A Population Pharmacokinetic Analysis.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: May 15, 2018
Exposure-response analysis for evaluation of semaglutide dose levels in type 2 diabetes.
Journal: Diabetes, obesity & metabolism
Published: February 19, 2018
Mathematical Modelling of Glucose-Dependent Insulinotropic Polypeptide and Glucagon-like Peptide-1 following Ingestion of Glucose.
Journal: Basic & clinical pharmacology & toxicology
Published: January 31, 2017
Impact of demographics and disease progression on the relationship between glucose and HbA1c.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: October 20, 2016
Methods for Predicting Diabetes Phase III Efficacy Outcome From Early Data: Superior Performance Obtained Using Longitudinal Approaches.
Journal: CPT: pharmacometrics & systems pharmacology
Published: July 27, 2016
Pharmacokinetic Properties of Liraglutide as Adjunct to Insulin in Subjects with Type 1 Diabetes Mellitus.
Journal: Clinical pharmacokinetics
Published: June 11, 2016
Liraglutide in Type 2 Diabetes Mellitus: Clinical Pharmacokinetics and Pharmacodynamics.
Journal: Clinical pharmacokinetics
Published: November 25, 2015
Establishing Good Practices for Exposure-Response Analysis of Clinical Endpoints in Drug Development.
Journal: CPT: pharmacometrics & systems pharmacology
Published: June 11, 2015
Last Updated: 09/26/2026